Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-01-08

FDA Approved: ACTEMRA — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved ACTEMRA (tocilizumab) under its original Biologics License Application from Genentech, for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actemra (tocilizumab)

Snippet

ORIG AP for ACTEMRA (TOCILIZUMAB)